Fabry's disease: Difference between revisions
Jump to navigation
Jump to search
Line 33: | Line 33: | ||
==[[Fabry's disease epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Fabry's disease epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[Fabry's disease risk factors|Risk Factors]]== | |||
==[[Fabry's disease screening|Screening]]== | |||
==[[Fabry's disease natural history, complications and prognosis|Natural History, Complications and Prognosis]] | |||
==Diagnosis== | ==Diagnosis== |
Revision as of 20:00, 22 August 2012
Template:DiseaseDisorder infobox
Fabry's disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Fabry's disease On the Web |
American Roentgen Ray Society Images of Fabry's disease |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]
Synonyms and keywords: Anderson-Fabry disease; angiokeratoma corporis diffusum universale; alpha-galactosidase A deficiency; ceramide trihexosidase deficiency; hereditary dystopic lipidosis; GLA deficiency; Sweeley-Klionsky disease
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Fabry's disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
==Natural History, Complications and Prognosis
Diagnosis
Treatment
External links
- Fabry Support & Information Group
- Template:NINDS
- Fabry's disease at NLM Genetics Home Reference
- Fabry's Disease Association